Citadel Advisors
DRIO icon

Citadel Advisors’s DarioHealth DRIO Stock Holding History

Citadel Advisors’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5
Closed -$79 – 14678
2024
Q4 		$79 Sell
5
-275
-98% -$4.76K ﹤0.01% 14387
2024
Q3 		$6.27K Buy
280
+115
+70% +$2.33K ﹤0.01% 13430
2024
Q2 		$3.93K Buy
165
+95
+136% +$2.69K ﹤0.01% 13529
2024
Q1 		$2.14K Sell
70
-35
-33% -$1.33K ﹤0.01% 14038
2023
Q4 		$3.61K Sell
105
-90
-46% -$3.21K ﹤0.01% 13575
2023
Q3 		$12.8K Sell
195
-230
-54% -$15.5K ﹤0.01% 12950
2023
Q2 		$34.1K Sell
425
-915
-68% -$69.5K ﹤0.01% 12228
2023
Q1 		$110K Sell
1,340
-245
-15% -$24.1K ﹤0.01% 11110
2022
Q4 		$136K Buy
1,585
+170
+12% +$15.3K ﹤0.01% 10761
2022
Q3 		$131K Buy
1,415
+755
+114% +$81K ﹤0.01% 10845
2022
Q2 		$81K Sell
660
-175
-21% -$20.5K ﹤0.01% 11584
2022
Q1 		$98K Sell
835
-1,470
-64% -$243K ﹤0.01% 12301
2021
Q4 		$598K Sell
2,305
-125
-5% -$38K ﹤0.01% 9230
2021
Q3 		$663K Buy
2,430
+175
+8% +$50.5K ﹤0.01% 9195
2021
Q2 		$963K Buy
2,255
+1,630
+261% +$621K ﹤0.01% 8463
2021
Q1 		$241K Buy
+625
New +$282K ﹤0.01% 11321

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citadel Advisors's DRIO Position: Q1 2026 in Review

Citadel Advisors opened a new position in DarioHealth (DRIO) in Q1 2026: 20,460 shares worth $164K. The stake represents ﹤0.01% of the portfolio and ranks #11607 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in DRIO as recently as Q4 2024.

Citadel Advisors first reported a position in DRIO in Q2 2018 and has held it in 21 quarters since. The position peaked at $895K in Q2 2022. 21 funds tracked by Wall St. Rank hold DRIO as of Q1 2026.

  • Citadel Advisors held 20,460 shares of DarioHealth worth $164K as of Q1 2026.
  • DarioHealth was a new Citadel Advisors position in Q1 2026.
  • DarioHealth made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11607 holding.
  • Citadel Advisors first reported a position in DarioHealth in Q2 2018 and has held it in 21 quarters since.
  • Citadel Advisors's DarioHealth position peaked at $895K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held DarioHealth as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.